PharmaACE- Analytics Center of Excellence

World's leading Pharma consulting organization with expertise in forecasting, competitive intelligence, business intelligence, sales analytics and more

[PharmaACE- Analytics Center of Excellence @PharmaAce]

PharmaACE started in 2013 with a handful of ‘PACERs’. Today we continue to grow from strength to strength. Scan the QR code below to know more about us.
#PharmaACE #Analytics #Pharma #AboutUs #QRCode #EmployeeGrowth #CustomerRetention #ClientRetention

[FierceBiotech @FierceBiotech]

Regeneron buys Checkmate for $250M to pick up skin cancer asset vidutolimod
https://t.co/PWlM6OpLzZ

[PharmaACE- Analytics Center of Excellence @PharmaAce]

We might think that it will be easy for us to separate Facts from Myths. Check out for yourself, how much you know about Men’s Health.

Quiz https://t.co/YWgZ6wRM6M

#menshealth #menshealthawareness #movember2021 #novembermenshealth #PharmaACE

Pic credit https://t.co/Rp6tZTlurB

[Bristol Myers Squibb @bmsnews]

We’re honored that a team of our scientists has been recognized with our fifth @AmerChemSociety #HeroesofChemistry Award for innovation that improves people’s lives. Learn more about the team’s work for #diabetes patients: https://t.co/CDtt1RiSFX

[AstraZeneca @AstraZeneca]

Lupus is commonly treated with oral corticosteroids, but long-term use of those treatments can cause significant side effects. Learn how we are advancing the scientific understanding of this immune-driven disease: https://t.co/uuCQLGVDlj #EULAR2021

[Amgen 🧪🔬🧬 @Amgen]

Today, Amgen is excited to announce the @US_FDA approval of the first and only targeted treatment specifically designed for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer #NSCLC.

$AMGN

[AstraZeneca @AstraZeneca]

Neurofibromatosis (NF) is an incurable condition caused by genetic mutations that occur spontaneously or are passed on from a parent. This May, we join the 2+ million people living with NF in raising awareness and advancing research to one day #EndNF.

[AstraZeneca @AstraZeneca]

Interested in understanding how we’re unlocking the information hidden within the human genome, with the aim of developing better medicines? This is the focus of this week’s @geneticsunzip podcast episode we’ve sponsored: https://t.co/3I9o16bcs4

[AstraZeneca @AstraZeneca]

Chronic #kidneydisease (CKD) can have a profound impact on a patient’s personal life. The CKD-Personal Impact Index presented at #ISNWCN is helping us to better understand the full burden of the disease. Registered HCP access only: https://t.co/Kap5ECj01s @ISNkidneycare

[European Pharmaceutical Review @PharmaReview]

Novavax has agreed to participate in the Com-COV2 study to evaluate the safety and efficacy of regimens consisting of doses of #Covid19 #vaccines from different manufacturers.
#clinicaltrials #biopharma #healthnews
Read the news: https://t.co/bLIPhzBtH0

[Moderna @moderna_tx]

Our approach to a #CMV vaccine #ModernaVaccinesDay

[Pharma Technology Focus @PharmaTechFocus]

Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special purpose acquisition company BCTG Acquisition, worth up to a total of approximately $353m

https://t.co/T6xqJvJrRk

[NIH @NIH]

News: NIH funds new influenza research network https://t.co/6dnKNUnD8U

[Bristol Myers Squibb @bmsnews]

#MEDIA: The @EMA_News has approved a new combination with our immunotherapy for the treatment of advanced #renalcellcarcinoma. https://t.co/vDDaNxBiFc

[AstraZeneca @AstraZeneca]

We are empowering the next generation of scientists to drive future advances in #STEM. Hear from our Chief Medical Officer, Ann Taylor, who will kick-off presentations from several scientific leaders at the @USAScienceFest #XSTEM All Access virtual event on April 21.

[Bristol Myers Squibb @bmsnews]

#MEDIA: Announcing the first disclosure of data from our Phase 3 trial evaluating the use of #immunotherapy before surgery for non-small cell #lungcancer. #AACR21 #LCSM https://t.co/nqT82j03m0

[FiercePharma @FiercePharma]

CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused on COVID https://t.co/My8YUDsRas

[FiercePharma @FiercePharma]

Moderna shells out for CEO security as its COVID-19 vaccine grabs the spotlight https://t.co/gJfJwuQCe9

[Abbott Cardiovascular @AbbottCardio]

The #CentriMag System surgical cannulas are the only VAD cannulas approved for 30-day use.
-34 FR Drainage (Venous)
-24 FR (Return)

Learn how they are designed for optimal flow characteristics that minimize thrombus formation and review US safety info:
https://t.co/aLiMBdWHyZ

[Bristol Myers Squibb @bmsnews]

In his remarks at the China Development Forum, CEO Giovanni Caforio said the company will expand its portfolio of medicines and scientific collaborations in China over the next five years. #innovation